Literature DB >> 28514831

Hypericum perforatum extract attenuates behavioral, biochemical, and neurochemical abnormalities in Aluminum chloride-induced Alzheimer's disease rats.

Zheng Cao1, Fan Wang2, Chunyu Xiu1, Jian Zhang1, Yanfei Li3.   

Abstract

Alzheimer's disease (AD) is a progressive and ultimately fatal neurodegenerative diseases. Aluminum, a neurotoxic metal, is considered as the pathological hallmark and contributing factor of AD. Hypericum perforatum extract (HPE) is a neuroprotective agent that can prevent neurodegenerative pathologies through antioxidants, anti-inflammatory and regulating neurotransmitter release in animal model of neuropathy. The present study aimed to identify the potential neuroprotective of HPE on AlCl3-induced AD rats. Rats were treated with AlCl3 for 90days to induce behavioral, biochemical, and neurochemical similar to AD. From 31thday, the rats were treated with HPE for 60days. Our results showed HPE improved cognitive function in AlCl3-induced AD rats, and attenuated AlCl3-induced increase in acetylcholinesterase activity and glutamic acid level as well as decreased in noradrenaline and dopamine level. In addition, HPE reversed AlCl3-induced hippocampal pathology including amyloid-beta (Aβ) accumulation (elevated Aβ42 level and amyloid plaques), oxidative stress (increased reactive oxygen species level and thiobarbituric acid reactive substances level, decreased glutathione level and superoxide dismutase activity) and neuroinflammatory (increased mRNA expressions of Interleukin-1β, Interleukin-6, Tumor necrosis factor-α and major histocompatibility complex class II) in hippocampus of rats. Thus, HPE is conferred neuroprotection against AlCl3-induced AD like pathology.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Aluminum chloride; Alzheimer’s disease; Hypericum perforatum extract; Neuroinflammatory; Neurotransmitter; Oxidative stress

Mesh:

Substances:

Year:  2017        PMID: 28514831     DOI: 10.1016/j.biopha.2017.05.022

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  5 in total

1.  Attenuation of Aluminum Chloride-Induced Neuroinflammation and Caspase Activation Through the AKT/GSK-3β Pathway by Hesperidin in Wistar Rats.

Authors:  Arokiasamy Justin-Thenmozhi; Mathiyazahan Dhivya Bharathi; Ramaraj Kiruthika; Thamilarasan Manivasagam; Anupom Borah; Musthafa Mohamed Essa
Journal:  Neurotox Res       Date:  2018-04-23       Impact factor: 3.911

2.  Identification of phytochemicals from North African plants for treating Alzheimer's diseases and of their molecular targets by in silico network pharmacology approach.

Authors:  Karim Raafat
Journal:  J Tradit Complement Med       Date:  2020-08-12

Review 3.  Potential of Caffeine in Alzheimer's Disease-A Review of Experimental Studies.

Authors:  Piotr Londzin; Milena Zamora; Beata Kąkol; Aleksandra Taborek; Joanna Folwarczna
Journal:  Nutrients       Date:  2021-02-06       Impact factor: 5.717

4.  Attenuative Effects of Fluoxetine and Triticum aestivum against Aluminum-Induced Alzheimer's Disease in Rats: The Possible Consequences on Hepatotoxicity and Nephrotoxicity.

Authors:  Karema Abu-Elfotuh; Ghada M Ragab; Ahmad Salahuddin; Lubna Jamil; Ekram Nemr Abd Al Haleem
Journal:  Molecules       Date:  2021-11-08       Impact factor: 4.411

5.  The Possible Neuroprotective Effect of Silymarin against Aluminum Chloride-Prompted Alzheimer's-Like Disease in Rats.

Authors:  Hanaa R Aboelwafa; Attalla F El-Kott; Eman M Abd-Ella; Hany N Yousef
Journal:  Brain Sci       Date:  2020-09-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.